The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.70BCNY
1.59B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
190.00x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Revenue (TTM)
1.78BCNY
263.90M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
3.43%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Beta
0.8570x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-11.77%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
10.70BCNY
1.59B · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
12.21BCNY
1.81B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
190.00x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Price to Sales (TTM)
6.39x
vs Medical Care Facilities peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 6.02×.Updated Aug 20, 2026
Price to Book (MRQ)
4.74x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Enterprise to Revenue
6.87x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Enterprise to EBITDA
59.76x
vs Medical Care Facilities peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 87.28×.Updated Aug 20, 2026
Gross Margin
20.52%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Profit Margin
3.43%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Operating Margin
6.28%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Return on Assets (TTM)
1.93%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Return on Equity (TTM)
1.56%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Revenue (TTM)
1.78BCNY
263.90M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
8.52CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
13.10%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Gross Profit (TTM)
387.93MCNY
57.62M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
139.84MCNY
20.77M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
60.90MCNY
9.05M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-60.80%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
227.21MCNY
33.75M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
-284.08MCNY
-42.19M · vs all stocks (USD)
Updated Aug 20, 2026
Payout Ratio
51.03%
vs Medical Care Facilities peers
Updated Aug 20, 2026
Minority Interest (Equity)
302.74MCNYFY2025 · Dec 31, 2025
Revenue
1.73BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.32BCNYFY2025 · Dec 31, 2025
Gross Profit
402.27MCNYFY2025 · Dec 31, 2025
Operating Income
149.24MCNY
22.16M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
119.64MCNYFY2025 · Dec 31, 2025
Income Tax Expense
47.31MCNYFY2025 · Dec 31, 2025
Net Income
72.33MCNYFY2025 · Dec 31, 2025
EBIT
133.68MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
246.58MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
70.30MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
10.59MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.81MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
14.05MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4100CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
205.32MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
205.32MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
72.33MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
11.86MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
94.92MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-491.27MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
380.49MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
72.33MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
35.11MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
3.83MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-16.35MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-586.20MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-283.60MCNYFY2025 · Dec 31, 2025
Sale of Investments
251.87MCNYFY2025 · Dec 31, 2025
Other Investing Activity
80.43MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-537.50MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
295.20MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.74MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-36.49MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-71.88MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
185.09MCNYFY2025 · Dec 31, 2025
Shares Outstanding
205.99MSharesUpdated Aug 20, 2026
Float Shares
157.95MSharesUpdated Aug 20, 2026
% Held by Insiders
38.27%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
4.77%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
438.07MCNY
65.06M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
2.16CNYUpdated Aug 20, 2026
Total Debt (MRQ)
714.43MCNY
106.11M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.2690x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Current Ratio (MRQ)
1.27x
vs Medical Care Facilities peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
11.61CNYUpdated Aug 20, 2026
Total Assets
3.91BCNY
580.68M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
658.66MCNYFY2025 · Dec 31, 2025
Total Liabilities
1.26BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.25BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
688.02MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
576.55MCNYFY2025 · Dec 31, 2025
Cash
445.03MCNYFY2025 · Dec 31, 2025
Cash Equivalents
2.69MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
447.72MCNYFY2025 · Dec 31, 2025
Accounts Receivable
108.90MCNYFY2025 · Dec 31, 2025
Inventory
63.21MCNYFY2025 · Dec 31, 2025
Accounts Payable
374.46MCNYFY2025 · Dec 31, 2025
Short-term Debt
41.30MCNYFY2025 · Dec 31, 2025
Long-term Debt
590.99MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
24.71MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
205.99MCNYFY2025 · Dec 31, 2025
Retained Earnings
586.15MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.65BCNY
392.86M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
104.19MCNYFY2025 · Dec 31, 2025
52-Week Low
46.83CNYUpdated Aug 20, 2026
52-Week High
103.00CNYUpdated Aug 20, 2026
52-Week Change
-11.77%
vs all stocks
Updated Aug 20, 2026
Beta
0.8570x
vs all stocks
Updated Aug 20, 2026
50-Day MA
53.05CNYUpdated Aug 20, 2026
200-Day MA
64.46CNYUpdated Aug 20, 2026
Avg 10-Day Volume
13.86MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
12.97MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
0.2900CNYUpdated Aug 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Where is this company structurally exposed?
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.87: safe zoneNotable
Altman Z-Score: 5.87
High earnings qualityNotable
Earnings Quality Score: 0.68
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $1.59B, above the global median of $1.15BNotable
Market cap (USD): 1,589,010,148.726Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.